← brief for 2026-10-07 · Slowing decline

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

Trial No results yet Not peer reviewed

Key takeaways

This is a new trial that is starting to test the drug semaglutide. It will look at how the drug affects body fat and the liver in people with kidney disease. There are no results yet.

Who did this work

Run by University of Alberta. Paolo Raggi, M.D (University of Alberta) · Luis G D'Marco, M.D; Ph,D. (CEU Cardenal Herrera University)
Sites: Mazankowski Alberta Heart Institute

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-10-07
https://clinicaltrials.gov/study/NCT07187830